Associate Director
Incyte
Associate Director
Incyte
Biopharmaceutical company pursuing drug discovery.
Overview
A global biopharmaceutical company on a mission to Solve On, Incyte follows science to find solutions for patients with unmet medical needs. Through the discovery, development, and commercialization of proprietary therapeutics, Incyte has established a portfolio of first-in-class medicines for patients and a strong pipeline of products in Hematology, Oncology and Inflammation and Autoimmunity.
Headquartered in Wilmington, Delaware, Incyte has operations in North America, Europe, and Asia.
Position Summary
The Global Head of Strategic Sourcing, Technical Operations is responsible for supporting the development and execution of global sourcing strategies related to Global Technical Operations across the enterprise. This role oversees category management, supplier strategy, and cost optimization initiatives spanning manufacturing, supply chain, engineering, and quality operations.
The individual will partner closely with Technical Operations leadership, R&D, Quality, and Finance to ensure supply continuity, drive operational excellence, and enable innovation across a complex global supplier ecosystem.
Key Responsibilities
Strategic Leadership
Category Management
Supplier Relationship Management
Cross-Functional Collaboration
Risk & Compliance
Team Leadership (if Director level)
Qualifications
Education
Experience
Industry Expertise
Key Performance Indicators (KPIs)
Incyte develops and sells medicines by discovering and developing new drugs, focusing on diseases in inflammation, autoimmunity, and blood cancers. Its core product, Jakafi (ruxolitinib), is a JAK1/2 inhibitor approved to treat a rare blood cancer and works by blocking JAK enzymes to reduce abnormal blood cell growth. The company also expands its pipeline through research collaborations, partnerships, and acquisitions, such as the 2024 purchase of Escient Pharmaceuticals to strengthen its inflammation and autoimmune portfolio. Unlike some competitors that rely mainly on internal programs, Incyte combines in-house discovery with external collaborations and strategic deals to grow its drug candidates from early research to approved therapies. The goal is to deliver medicines that help patients with serious diseases by building a diverse, clinically validated portfolio of treatments through internal efforts and partnerships.
Explore more opportunities at Incyte